Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Holechek, Susan A., Denzler, Karen L., Heck, Michael C., Schriewer, Jill, Buller, R. Mark, Legrand, Fatema A., Verardi, Paulo H., Jones, Leslie A., Yilma, Tilahun, Jacobs, Bertram L.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://ncbi.nlm.nih.gov/pubmed/24147092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077879
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars